United States · FDA National Drug Code directory
Sertraline Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84386-097_b497dfeb-a48c-4f2a-b309-b56f3a26a19b
- Product NDC
- 84386-097
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sertraline Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251120
- Source listing expiry
- 20261231
Source-listed ingredients
- SERTRALINE HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (84386-097-01) · 84386-097-01
- 500 TABLET, FILM COATED in 1 BOTTLE (84386-097-05) · 84386-097-05
- 30 TABLET, FILM COATED in 1 BOTTLE (84386-097-30) · 84386-097-30
- 50 TABLET, FILM COATED in 1 BOTTLE (84386-097-50) · 84386-097-50
- 5000 TABLET, FILM COATED in 1 BOTTLE (84386-097-51) · 84386-097-51
- 60 TABLET, FILM COATED in 1 BOTTLE (84386-097-60) · 84386-097-60
- 90 TABLET, FILM COATED in 1 BOTTLE (84386-097-90) · 84386-097-90
- 1000 TABLET, FILM COATED in 1 BOTTLE (84386-097-99) · 84386-097-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →